M05.352, Rheumatoid heart disease with rheumatoid arthritis of left hipICD-10-CM
No Prior Auth Required
Covered without prior authorization by at least one policy, though another does not cover it (medium confidence)
CGS-J15-L34399, Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography)
J15
CGS-J15-L33959, Cardiac Catheterization and Coronary Angiography
J15
CGS-J18-L34399, Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography)
J18
CGS-J18-L33959, Cardiac Catheterization and Coronary Angiography
J18
A55639, Billing and Coding: Chemotherapy Agents for Non-Oncologic Conditions
J5
WPS-J5-L34633, Erythropoiesis Stimulating Agents (ESAs)
J5
WPS-J5-L37205, Chemotherapy Drugs and their Adjuncts
J5
A56795, Billing and Coding: Erythropoiesis Stimulating Agents (ESAs)
J5
A59434, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J5
NGS-J6-L33394, Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
J6
A52850, Billing and Coding: Cardiac Catheterization and Coronary Angiography
J6
A52423, Billing and Coding: Infliximab and biosimilars
J6
A58893, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J6
NGS-J6-L39297, Off-label Use of Rituximab and Rituximab Biosimilars
J6
NGS-J6-L33557, Cardiac Catheterization and Coronary Angiography
J6
A59101, Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars
J6
WPS-J8-L34633, Erythropoiesis Stimulating Agents (ESAs)
J8
WPS-J8-L37205, Chemotherapy Drugs and their Adjuncts
J8
A57657, Billing and Coding: Sedimentation Rate, Erythrocyte
J9
FIRST_COAST-L34021, Sedimentation Rate, Erythrocyte
J9
Ask Backwork about documentation requirements, denial risks, or coverage in your state.